Business news with perspective

Sabey Data Centers promises jobs, tax revenue, and a new aquatic center. But as Decatur Township grapples with this digital giant, a question emerges: What is the true cost of progress?

GRI Bio showcases its promising IPF drug, GRI-0621, in a new webcast, aiming to capture investor and scientific attention before a key industry congress.

Mihir Shah, the architect of Fidelity's massive data platform, joins AtScale's board to champion the semantic layer as the key to reliable, business-ready AI.

As a wall of maturing debt challenges commercial real estate, private credit firms like BridgeInvest are stepping in to fill a critical financing gap.

A new initiative aims to turn old factories into clean energy hubs. But can a digital toolkit truly bridge the gap between innovation and community renewal?

A new survey shows Americans are more comfortable with video surveillance, but this acceptance comes with a steep price: absolute transparency and ethical use.

At TETS 2026, LiquidPiston isn't just showing an engine; it's signaling a strategic bid to solve the military's most pressing power and logistics problems.

With a potential $18M DOE boost, Frontier Antimony Refinery plans to reshore a critical military metal, breaking U.S. dependence on China and Russia.

Jerusalem is equipping 10,000 city workers with an AI security platform. Is this the future of urban safety or a new form of privatized policing?

Disney's new 967-room Lakeshore Lodge blends IP with nature. We analyze its impact on the luxury market and what it means for DVC members.

In a market grappling with high vacancy, LaSalle Investment Management's stake in Houston's CityWest campus highlights a strategic bet on amenity-rich properties.

Manycore Tech's new Lux3D model generates 3D assets in seconds, but the real story is its bet on an 'explicit 3D' path to AI world models.

A new partnership promises a massive AI data center. But this is more than a deal—it's a high-stakes bet on specialized tech and a smaller firm's big break.

Cardurion is set to reveal pivotal Phase 2 data for Tovinontrine, a first-in-class drug aiming to help millions suffering from chronic heart failure.

NexPoint's new marina fund reveals a trend: institutional cash flowing into niche waterfront assets. But are these safe harbors or risky waters for investors?

As AI accelerates code production to breakneck speeds, a new class of silent, logic-based flaws emerges. Sonar's new agent is designed to hunt them.

A new partnership between Enabled Intelligence and Seekr promises to bring auditable, explainable AI to critical national security missions, including the NGA.

With its new DORC EVA NEXUS system, ZEISS isn't just launching a product; it's making a strategic play to dominate the high-stakes cataract surgery market.

Beyond a routine press release, Okta's upcoming investor conference is a critical test of its AI-centric vision and financial footing. What's really at stake?

A new report reveals 330x markups and sweeping Chinese regulations are turning the humble syringe into the new frontier of profit, risk, and power in aesthetics.